Readoutin 14d
Ausper Biopharma Co., Ltd. — AHB-137
Phase 3 primary completion: Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE).
- Date
- Dec 2026
- Type
- Readout
- Indication
- Chronic Hepatitis B